Tag Archives: Challenge

J&J’s next COVID-19 vaccine challenge? Hurdling the ‘66%’ perception to win over a vaccine-hesitant public

With an FDA green light for emergency use, Johnson & Johnson’s COVID-19 shot now faces a communications hurdle. How will the company handle the comparisons with its vaccine rivals? Already, there’s wide and spreading chatter on social media and real-world word-of-mouth discussions about the J&J shot’s 66% overall effectiveness rate. The company’s response has been communication—and lots of… Read More »

In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche’s Polivy

The FDA hasn’t specifically approved a therapy for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma after an initial line of therapy—until now. MorphoSys and Incyte’s Monjuvi—also known as tafasitamab—in combination with Celgene’s Revlimid now represents the first FDA-approved second-line regimen for DLBCL, the two companies said Friday. Because of Monjuvi’s importance… Read More »

2018 Winter Waistline Challenge Begins

Tuesday, November 27, 2018 The holidays…decorations, family, friends, cheer, and relaxation as we near the end of the year.  Oh, and probably feeling a bit sluggish from high sugar/alcohol intake, stress, lack of exercise and subsequent weight gain. What if we embraced all that’s great about the holidays and just left the rest. Wouldn’t it… Read More »